Clinical Trials Logo

Clinical Trial Summary

Environmental stress, such as low oxygen availability (hypoxia), has been associated with impaired neuromuscular performance; however, the mechanisms associated with these performance decrements remain unclear. While the majority of research suggests that the observed fatigue is related to the central nervous system, the influence of changes in cerebral blood flow (CBF) and associated changes in cerebral pH (partial pressure of carbon dioxide; PCO2) remains unexamined. In response to hypoxic stress, humans hyperventilate to maintain oxygen consumption, resulting in a hypocapnia mediated decrease in CBF and cerebral alkalosis (decreased PCO2). Previous research suggests that hyperventilation induces changes in neural excitability and synaptic transmission; however, it remains unclear if these changes are related to hypocapnia mediated decrease in CBF or cerebral alkalosis or both.

The purpose of the proposed research program is to examine the influence of changes in CBF and cerebral alkalosis on neuromuscular function during environmental stress. The research program will consist of 2 separate projects, summarized below in a table outlining the proposed protocols and resultant physiological manipulations. During each manipulation, neuromuscular function will be evaluated and compared to baseline (normoxic) conditions using a repeated measures design.

The research program will consist of 2 separate projects. Project 1 will examine the changes in CBF and alkalosis by using (a) indomethacin (decrease CBF; no change PCO2) and (b) hypocapnia (decrease CBF; decrease PCO2). Using a similar experimental design, Project 2 will examine the change in CBF and alkalosis during hypoxia by using (a) poikilocapnic hypoxia (decrease PO2; decrease CBF; decrease PCO2), (b) isocapnic hypoxia (decrease PO2; no change CBF; no change PCO2) and (c) isocapnic hypoxia + indomethacin (decrease PO2; decrease CBF; no change PCO2). During each manipulation, neuromuscular function will be evaluated and compared to baseline (normoxic) conditions using a repeated measures design.

Therefore, Project 1 will examine the separate and combined effect of changes in CBF and cerebral alkalosis on neuromuscular function independent of environmental manipulations. Subsequently, Project 2 will examine neuromuscular function during hypoxia while controlling CBF and cerebral alkalosis. It is hypothesized that changes in PCO2 and therefore, changes in cerebral alkalosis will contribute to neuromuscular fatigue independent of changes in CBF and oxygen availability.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01830335
Study type Interventional
Source Brock University
Contact
Status Completed
Phase Phase 4
Start date April 2013
Completion date December 2016

See also
  Status Clinical Trial Phase
Recruiting NCT04234594 - Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males. Phase 1
Completed NCT01367561 - Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function Phase 1
Completed NCT00777543 - Increasing Ferulic Acid Bioavailability in Bran N/A
Recruiting NCT04756635 - Effects of Short- Term Intermittent Fasting Aerobic and Anaerobic Capacity N/A
Completed NCT02156661 - Oxytocin and Emotion Processing Phase 1
Completed NCT01848665 - The Influence of Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Passive Heat Stress Phase 4
Completed NCT05294198 - Beetroot Extract and Its Influence on Cardiovascular and Autonomic Recovery From the Effort in Healthy Males N/A
Completed NCT00839319 - HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone Phase 1/Phase 2
Completed NCT00842751 - Oral T7 Oral Testosterone in Man Phase 2
Completed NCT01847053 - Bioavailability Study of Cinnamon in Healthy Subjects Phase 1/Phase 2
Completed NCT01215292 - ITT4 Intratesticular Hormonal Milieu in Man (ITT4) Phase 1/Phase 2
Completed NCT00782392 - Bioavailability and Dosing of a Monosaccharide Supplement in Adults N/A
Completed NCT03714685 - Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations Phase 1
Completed NCT05277597 - Effect of a 4-week Post-exercise Sauna Bathing on Targeted Gut Microbiota N/A
Completed NCT01032616 - Uptake and Utilization of Amino Acids by Splanchnic Bed Phase 1
Completed NCT00902512 - Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations Phase 4
Completed NCT00475371 - A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males Phase 1
Completed NCT01870102 - Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects Phase 1